Table 3

Number and proportion of patients monitored and treated according to fever protocol

 Statewide aggregateQASC trial
ElementMonitoring and treatment for feverPreimplementation audit
(n=1062)
Postimplementation audit
(n=1082)
OR (95% CI)p ValueIntervention group (n=603)
Monitoring
M1Temperature recorded at least four times on day 1924 (87%)1025 (95%)2.68 (1.60 to 4.50)0.0002545 (93%)
M2Temperature recorded at least four times on day 2861 (84%)940 (91%)1.89 (1.30 to 2.76)0.0009482 (82%)
M3Temperature recorded at least four times on day 3764 (82%)833 (88%)1.56 (1.11 to 2.20)0.011379 (64%)
Monitoring adherence*
Monitored according to protocol for fever802 (76%)906 (84%)1.66 (1.18 to 2.34)0.0033337 (56%)
     Treatment
At least one febrile event (temperature≥37.5°C)149 (14%)135 (12%)0.89 (0.65 to 1.21)0.45105 (17%)
T1Received paracetamol within 1 h of their first febrile event (temperature≥37.5°C)57 (38%)64 (47%)1.45 (0.95 to 2.20)0.0819 (18%)
Protocol adherence: monitored and treated
Monitored and treated according to the protocol for fever729 (69%)845 (78%)1.62 (1.18 to 2.24)0.0031258 (44%)
  • Day 1 indicates first 24 h since admission to hospital. The protocol recommends that observations should be taken at least six hourly, so there should be at least four separate temperature recordings during the first 24 h of admission.

  • Statistically significant p values are shown in bold.

  • *Must meet all M1, M2 and M3 to be deemed as having been monitored according to protocol.

  • †Must meet all M1, M2, M3 and T1 to be deemed as having been monitored and treated according to protocol.

  • QASC, Quality in Acute Stroke Care.